Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia
Gespeichert in:
| Veröffentlicht in: | Pediatrics international 2020-03, Vol.62 (3), p.403-405 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 405 |
|---|---|
| container_issue | 3 |
| container_start_page | 403 |
| container_title | Pediatrics international |
| container_volume | 62 |
| creator | Akane, Yusuke Yamamoto, Masaki Igarashi, Keita Takebayashi, Akira Hori, Tsukasa |
| description | |
| doi_str_mv | 10.1111/ped.14079 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_proquest_journals_2385869950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2385869950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3779-cee0084830d258b79b6d25bdd34da46243fa513d7989931cc63bbeb8259c6b2c3</originalsourceid><addsrcrecordid>eNqNkclKNDEQgIMo7gdfQBo8ibRm6SU5_owrCHpQ8GSTpQajvdlJI3PzEXxGn8QaZ_T2g7mkqHxVqXwhZI_RY4brpAd3zDJaqhWyybKMp5zSh1WMBZeppEW5QbZCeKaUylJm62RDcMq5kGyTPN7C0OgW2pj4Noy1bz_fPxz00Lp5znltIEJIGqhrH8eAVKKTXkc_P37z8SnRdoyQ1LOmf-pMrUP0NqlhfIHG6x2yNtV1gN3lvk3uz8_uJpfp9c3F1eTfdWpFWarUAuBsmRTU8VyaUpkCA-OcyJzOCp6Jqc6ZcKWSSglmbSGMASN5rmxhuBXb5GDRtx-61xFCrJ67cWjxygrfmctCqZwidbig7NCFMMC06gff6GFWMVrNTVZosvo2iez-suNoGsz-kD_qEDhaAG9gummwKMTCL4auc0ZVjj-Ba07Lv9MTH1Fw1066sY1YerIs9TXM_j9ydXt2upj9C0TGn34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2385869950</pqid></control><display><type>article</type><title>Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Akane, Yusuke ; Yamamoto, Masaki ; Igarashi, Keita ; Takebayashi, Akira ; Hori, Tsukasa</creator><creatorcontrib>Akane, Yusuke ; Yamamoto, Masaki ; Igarashi, Keita ; Takebayashi, Akira ; Hori, Tsukasa</creatorcontrib><identifier>ISSN: 1328-8067</identifier><identifier>EISSN: 1442-200X</identifier><identifier>DOI: 10.1111/ped.14079</identifier><identifier>PMID: 32022381</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Acute lymphoblastic leukemia ; Adolescent ; Adrenal Cortex Hormones - adverse effects ; Adrenal Cortex Hormones - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - adverse effects ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Asparaginase - adverse effects ; Asparaginase - therapeutic use ; Blood Glucose - analysis ; corticosteroid ; Cyclophosphamide - adverse effects ; Cyclophosphamide - therapeutic use ; Cytarabine - adverse effects ; Cytarabine - therapeutic use ; Dexamethasone - adverse effects ; Dexamethasone - therapeutic use ; Diabetes mellitus ; Diabetes Mellitus, Type 1 - chemically induced ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - drug therapy ; Doxorubicin - adverse effects ; Doxorubicin - therapeutic use ; Humans ; Hyperglycemia - chemically induced ; Hyperglycemia - diagnosis ; Hyperglycemia - drug therapy ; Hypoglycemic Agents - therapeutic use ; IDDM ; Insulin ; Insulin - therapeutic use ; Life Sciences & Biomedicine ; Lymphatic leukemia ; L‐asparaginase ; Male ; Pediatrics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Science & Technology ; Thioguanine - adverse effects ; Thioguanine - therapeutic use ; Treatment Outcome ; Vincristine - adverse effects ; Vincristine - therapeutic use</subject><ispartof>Pediatrics international, 2020-03, Vol.62 (3), p.403-405</ispartof><rights>2020 Japan Pediatric Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>0</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000510952000001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3779-cee0084830d258b79b6d25bdd34da46243fa513d7989931cc63bbeb8259c6b2c3</citedby><cites>FETCH-LOGICAL-c3779-cee0084830d258b79b6d25bdd34da46243fa513d7989931cc63bbeb8259c6b2c3</cites><orcidid>0000-0002-0288-7990</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fped.14079$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fped.14079$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,28255,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32022381$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akane, Yusuke</creatorcontrib><creatorcontrib>Yamamoto, Masaki</creatorcontrib><creatorcontrib>Igarashi, Keita</creatorcontrib><creatorcontrib>Takebayashi, Akira</creatorcontrib><creatorcontrib>Hori, Tsukasa</creatorcontrib><title>Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia</title><title>Pediatrics international</title><addtitle>PEDIATR INT</addtitle><addtitle>Pediatr Int</addtitle><subject>Acute lymphoblastic leukemia</subject><subject>Adolescent</subject><subject>Adrenal Cortex Hormones - adverse effects</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - adverse effects</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Asparaginase - adverse effects</subject><subject>Asparaginase - therapeutic use</subject><subject>Blood Glucose - analysis</subject><subject>corticosteroid</subject><subject>Cyclophosphamide - adverse effects</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Cytarabine - adverse effects</subject><subject>Cytarabine - therapeutic use</subject><subject>Dexamethasone - adverse effects</subject><subject>Dexamethasone - therapeutic use</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 1 - chemically induced</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Doxorubicin - adverse effects</subject><subject>Doxorubicin - therapeutic use</subject><subject>Humans</subject><subject>Hyperglycemia - chemically induced</subject><subject>Hyperglycemia - diagnosis</subject><subject>Hyperglycemia - drug therapy</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>IDDM</subject><subject>Insulin</subject><subject>Insulin - therapeutic use</subject><subject>Life Sciences & Biomedicine</subject><subject>Lymphatic leukemia</subject><subject>L‐asparaginase</subject><subject>Male</subject><subject>Pediatrics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Science & Technology</subject><subject>Thioguanine - adverse effects</subject><subject>Thioguanine - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Vincristine - adverse effects</subject><subject>Vincristine - therapeutic use</subject><issn>1328-8067</issn><issn>1442-200X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkclKNDEQgIMo7gdfQBo8ibRm6SU5_owrCHpQ8GSTpQajvdlJI3PzEXxGn8QaZ_T2g7mkqHxVqXwhZI_RY4brpAd3zDJaqhWyybKMp5zSh1WMBZeppEW5QbZCeKaUylJm62RDcMq5kGyTPN7C0OgW2pj4Noy1bz_fPxz00Lp5znltIEJIGqhrH8eAVKKTXkc_P37z8SnRdoyQ1LOmf-pMrUP0NqlhfIHG6x2yNtV1gN3lvk3uz8_uJpfp9c3F1eTfdWpFWarUAuBsmRTU8VyaUpkCA-OcyJzOCp6Jqc6ZcKWSSglmbSGMASN5rmxhuBXb5GDRtx-61xFCrJ67cWjxygrfmctCqZwidbig7NCFMMC06gff6GFWMVrNTVZosvo2iez-suNoGsz-kD_qEDhaAG9gummwKMTCL4auc0ZVjj-Ba07Lv9MTH1Fw1066sY1YerIs9TXM_j9ydXt2upj9C0TGn34</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Akane, Yusuke</creator><creator>Yamamoto, Masaki</creator><creator>Igarashi, Keita</creator><creator>Takebayashi, Akira</creator><creator>Hori, Tsukasa</creator><general>Wiley</general><general>Blackwell Publishing Ltd</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0002-0288-7990</orcidid></search><sort><creationdate>202003</creationdate><title>Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia</title><author>Akane, Yusuke ; Yamamoto, Masaki ; Igarashi, Keita ; Takebayashi, Akira ; Hori, Tsukasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3779-cee0084830d258b79b6d25bdd34da46243fa513d7989931cc63bbeb8259c6b2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acute lymphoblastic leukemia</topic><topic>Adolescent</topic><topic>Adrenal Cortex Hormones - adverse effects</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - adverse effects</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Asparaginase - adverse effects</topic><topic>Asparaginase - therapeutic use</topic><topic>Blood Glucose - analysis</topic><topic>corticosteroid</topic><topic>Cyclophosphamide - adverse effects</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Cytarabine - adverse effects</topic><topic>Cytarabine - therapeutic use</topic><topic>Dexamethasone - adverse effects</topic><topic>Dexamethasone - therapeutic use</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 1 - chemically induced</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Doxorubicin - adverse effects</topic><topic>Doxorubicin - therapeutic use</topic><topic>Humans</topic><topic>Hyperglycemia - chemically induced</topic><topic>Hyperglycemia - diagnosis</topic><topic>Hyperglycemia - drug therapy</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>IDDM</topic><topic>Insulin</topic><topic>Insulin - therapeutic use</topic><topic>Life Sciences & Biomedicine</topic><topic>Lymphatic leukemia</topic><topic>L‐asparaginase</topic><topic>Male</topic><topic>Pediatrics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Science & Technology</topic><topic>Thioguanine - adverse effects</topic><topic>Thioguanine - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Vincristine - adverse effects</topic><topic>Vincristine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akane, Yusuke</creatorcontrib><creatorcontrib>Yamamoto, Masaki</creatorcontrib><creatorcontrib>Igarashi, Keita</creatorcontrib><creatorcontrib>Takebayashi, Akira</creatorcontrib><creatorcontrib>Hori, Tsukasa</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Pediatrics international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akane, Yusuke</au><au>Yamamoto, Masaki</au><au>Igarashi, Keita</au><au>Takebayashi, Akira</au><au>Hori, Tsukasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia</atitle><jtitle>Pediatrics international</jtitle><stitle>PEDIATR INT</stitle><addtitle>Pediatr Int</addtitle><date>2020-03</date><risdate>2020</risdate><volume>62</volume><issue>3</issue><spage>403</spage><epage>405</epage><pages>403-405</pages><issn>1328-8067</issn><eissn>1442-200X</eissn><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>32022381</pmid><doi>10.1111/ped.14079</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0288-7990</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1328-8067 |
| ispartof | Pediatrics international, 2020-03, Vol.62 (3), p.403-405 |
| issn | 1328-8067 1442-200X |
| language | eng |
| recordid | cdi_proquest_journals_2385869950 |
| source | MEDLINE; Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
| subjects | Acute lymphoblastic leukemia Adolescent Adrenal Cortex Hormones - adverse effects Adrenal Cortex Hormones - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Asparaginase - adverse effects Asparaginase - therapeutic use Blood Glucose - analysis corticosteroid Cyclophosphamide - adverse effects Cyclophosphamide - therapeutic use Cytarabine - adverse effects Cytarabine - therapeutic use Dexamethasone - adverse effects Dexamethasone - therapeutic use Diabetes mellitus Diabetes Mellitus, Type 1 - chemically induced Diabetes Mellitus, Type 1 - diagnosis Diabetes Mellitus, Type 1 - drug therapy Doxorubicin - adverse effects Doxorubicin - therapeutic use Humans Hyperglycemia - chemically induced Hyperglycemia - diagnosis Hyperglycemia - drug therapy Hypoglycemic Agents - therapeutic use IDDM Insulin Insulin - therapeutic use Life Sciences & Biomedicine Lymphatic leukemia L‐asparaginase Male Pediatrics Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Science & Technology Thioguanine - adverse effects Thioguanine - therapeutic use Treatment Outcome Vincristine - adverse effects Vincristine - therapeutic use |
| title | Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T20%3A40%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Permanent%20insulin%E2%80%90dependent%20diabetes%20mellitus%20in%20a%20patient%20with%20acute%20lymphoblastic%20leukemia&rft.jtitle=Pediatrics%20international&rft.au=Akane,%20Yusuke&rft.date=2020-03&rft.volume=62&rft.issue=3&rft.spage=403&rft.epage=405&rft.pages=403-405&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.14079&rft_dat=%3Cproquest_webof%3E2385869950%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2385869950&rft_id=info:pmid/32022381&rfr_iscdi=true |